4D MOLECULAR THERAPEUTICS, INC. (FDMT)
4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical